[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370085-105":59,"doc-detail-370085-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","insights-into-extracellular-vesicle-based-platforms-on-the-way-to-cancer-treatment","Insights into extracellular vesicle-based platforms on the way to cancer treatment","","Exosomes are nanoscale extracellular vesicles defined by a lipid bilayer that encloses aqueous content, enabling simultaneous encapsulation of hydrophobic, hydrophilic, and amphipathic compounds. Their endogenous biogenesis supports high biocompatibility, low immunogenicity, and evasion of rapid clearance while crossing biological barriers. Surface antigens provide innate specificity, supporting targeted uptake, and engineered or hybrid exosome systems can deliver nanoparticles, drugs, nucleic acids, and contrast agents to improve therapeutic efficacy and diagnostic sensitivity. A literature review assesses therapeutic and diagnostic progress up to 2025 and highlights remaining challenges such as characterization, purification costs, standardization, and safety.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/insights-into-extracellular-vesicle-based-platforms-on-the-way-to-cancer-treatment/370085/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/insights-into-extracellular-vesicle-based-platforms-on-the-way-to-cancer-treatment/370085.png","ImageObject",300,407,{"name":92,"@type":93},"anakgang17","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What are exosomes and why are they relevant to cancer treatment and diagnosis?","Question",{"text":112,"@type":113},"Exosomes are nanoscale extracellular vesicles with a lipid bilayer that can encapsulate diverse cargo. Their biological properties and retained surface antigens support specificity and stability, enabling applications in targeted cancer therapy and improved diagnostics.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were studies selected in this review?",{"text":117,"@type":113},"The review conducted a comprehensive literature search across PubMed, Scopus, and Google Scholar, focusing on therapeutic and diagnostic applications of exosomes in cancer. It included engineered and hybrid systems and extended coverage to the most recent publications up to 2025.",{"name":119,"@type":110,"acceptedAnswer":120},"What benefits do hybrid exosome-based systems offer compared with traditional approaches?",{"text":121,"@type":113},"The review reports that hybridized exosome systems have exceeded traditional techniques by improving delivery of therapeutic agents and strengthening diagnostic accuracy. They also expand translational potential across medication/gene delivery, diagnostics, and hybrid carrier development.",{"name":123,"@type":110,"acceptedAnswer":124},"What challenges still need to be addressed for clinical translation?",{"text":125,"@type":113},"Key challenges include costly purification, difficulty in accurate characterization, lack of standardized characterization methods, and safety issues with potential side effects. Addressing these obstacles is needed to support clinical translation of exosome-based therapy.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},370085,1790252100,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":24,"preview_urls":150},962090883568,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Bagheri etal. Journal of Translational Medicine (2026) 24:105  \n[https://doi.org/10.1186/s12967-025-07554-4](https://doi.org/10.1186/s12967-025-07554-4)  \nJournal of Translational Medicine  \nREVIEW Open Access  \nInsights into extracellular vesicle-based platforms on the way to cancer treatment  \nEl naz Bagheri 1, Elahehsadat Aminyazdi 1, Mohammad Ramezani 1,2, Marzieh Mohammadi3,4, Khalil Abnous 1, Seyed Mohammad Taghdisi3 and Mona Alibolandi 1,2*  \nAbstract  \nBackground Exosomes are nanoscale extracellular vesicles (EVs) (≈30–150 nm) defined by a lipid bilayer that encloses an aqueous interior. This amphiphil ic architecture permits the simultaneous encapsulation of hydrophobic, hydrophilic, and amphipathic compounds. Their endogenous biogenesis results in high biocompatibility, negligible immunogenicity, and the capacity to evade rapid clearance while crossing biological barriers. Additionally, the Surface antigens retained from the cell of origin provide exosomes with innate specificity, enabling efficient  \nuptake by specific cell subpopulations. Studies have successfully engineered exosomes to transport inorganic nanoparticles, chemotherapeutic drugs, nucleic acids, and contrast agents, resulting in enhanced therapeutic efficacy and diagnostic sensitivity. Hybrid exosome systems, which integrate exosomes with supplementary carriers such as polymers, lipids, and nanoparticles, have been developed to further enhance their efficacy and expand the translational potential of exosome-based nanomedicine.  \nMethods A comprehensive literature search was conducted across PubMed, Scopus, and Google Scholar to identify relevant studies focusing on the therapeutic and diagnostic applications of exosomes in cancer, including engineered and hybrid exosome systems. It was extended to include the most recent publications up to and including those released in 2025. Full texts were reviewed to extract key information regarding study design, exosome source and modification, cargo type, delivery mechanism, and reported outcomes.  \nResults Research has shown that exosomes can efficiently deliver therapeutic agents, greatly improving the effectiveness of targeted cancer treatments and the accuracy of diagnostics. Particularly, hybridized exosome-based systems have exceeded traditional techniques. Despite the limitations, such as the high expense and difficulty of accurate characterization, exosome-based systems have successfully penetrated various domains, including medication and gene delivery, diagnostics, and the development of hybrid carriers.  \nConclusion Exosomes represent a flexible and promising platform for cancer diagnostics and treatment. Recent developments, particularly of hybrid exosome systems, have further boosted their therapeutic versatility and addressed some of the most significant drawbacks of native exosome technologies. Nevertheless, several challenges remain to be overcome, including the costly nature of purification, standardization of characterization methods, and safety issues and potential side effects. Overcoming these obstacles will ensure the clinical translation of exosomebased therapy.  \n*Correspondence:  \nMona Alibolandi [alibolandim@mums.ac.ir](alibolandim@mums.ac.ir)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated oth","cbCaioCXFwIPS0Vg","https://ap.wps.com/l/cbCaioCXFwIPS0Vg","pdf",4854098,48,"English","# Abstract\n# Keywords\n# Introduction\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What are exosomes and why are they relevant to cancer treatment and diagnosis?\",\"answer\":\"Exosomes are nanoscale extracellular vesicles with a lipid bilayer that can encapsulate diverse cargo. Their biological properties and retained surface antigens support specificity and stability, enabling applications in targeted cancer therapy and improved diagnostics.\"},{\"question\":\"How were studies selected in this review?\",\"answer\":\"The review conducted a comprehensive literature search across PubMed, Scopus, and Google Scholar, focusing on therapeutic and diagnostic applications of exosomes in cancer. It included engineered and hybrid systems and extended coverage to the most recent publications up to 2025.\"},{\"question\":\"What benefits do hybrid exosome-based systems offer compared with traditional approaches?\",\"answer\":\"The review reports that hybridized exosome systems have exceeded traditional techniques by improving delivery of therapeutic agents and strengthening diagnostic accuracy. They also expand translational potential across medication/gene delivery, diagnostics, and hybrid carrier development.\"},{\"question\":\"What challenges still need to be addressed for clinical translation?\",\"answer\":\"Key challenges include costly purification, difficulty in accurate characterization, lack of standardized characterization methods, and safety issues with potential side effects. Addressing these obstacles is needed to support clinical translation of exosome-based therapy.\"}]","Insights into extracellular vesicle-based platforms on the way to cancer treatment | PDF",1790186627,121,[151,155,159,163,167],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7bd7ac2ec7650b510a9a6ce3ca79bc0d.webp",983,1310,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9bfeda825ce7180bf2f943e6ae3c5ce3.webp",982,1309,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2535b3dfe283a2b1cc47bdfd0cc4fc4a.webp",981,1308,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/48764751881d28b2a894f8a594ad221c.webp",980,1306,{"page_no":24,"url":168,"width":169,"height":170},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96a882738ec1c6da00149b12024dbae2.webp",979,1305]